for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Takeda & Novavax Announce Collaboration For Novavax' COVID-19 Vaccine Candidate In Japan

Aug 7 (Reuters) - Takeda Pharmaceutical Co Ltd:

* NOVAVAX AND TAKEDA ANNOUNCE COLLABORATION FOR NOVAVAX’ COVID-19 VACCINE CANDIDATE IN JAPAN

* SEES CAPACITY TO MANUFACTURE OVER 250 MILLION DOSES OF COVID-19 VACCINE PER YEAR

* NOVAVAX & TAKEDA TO PARTNER FOR DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION OF NVX-COV2373 IN JAPAN

* NOVAVAX WILL LICENSE & TRANSFER MANUFACTURING TECHNOLOGIES TO ENABLE TAKEDA TO MANUFACTURE VACCINE ANTIGEN

* TO RECEIVE FUNDING FROM JAPAN'S MINISTRY OF HEALTH, LABOUR AND WELFARE TO SUPPORT MANUFACTURING Source text bit.ly/2Ca25GQ Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up